These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8652784)

  • 41. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
    Brown SA; Breton MD; Anderson SM; Kollar L; Keith-Hynes P; Levy CJ; Lam DW; Levister C; Baysal N; Kudva YC; Basu A; Dadlani V; Hinshaw L; McCrady-Spitzer S; Bruttomesso D; Visentin R; Galasso S; Del Favero S; Leal Y; Boscari F; Avogaro A; Cobelli C; Kovatchev BP
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3674-3682. PubMed ID: 28666360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of computer-assisted insulin delivery in patients with type I diabetes beginning pump therapy.
    Peterson CM; Jovanovic L; Chanoch LH
    Am J Med; 1986 Jul; 81(1):69-72. PubMed ID: 3524226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
    Raviteja KV; Kumar R; Dayal D; Sachdeva N
    Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study.
    Halimi S; Charpentier G; Grimaldi A; Grenier JL; Baut F; Germain B; Magnette J
    Diabetes Metab; 2001 Dec; 27(6):681-7. PubMed ID: 11852377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Modular Safety System for an Insulin Dose Recommender: A Feasibility Study.
    Liu C; Avari P; Leal Y; Wos M; Sivasithamparam K; Georgiou P; Reddy M; Fernández-Real JM; Martin C; Fernández-Balsells M; Oliver N; Herrero P
    J Diabetes Sci Technol; 2020 Jan; 14(1):87-96. PubMed ID: 31117804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.
    Weiss R; Garg SK; Bode BW; Bailey TS; Ahmann AJ; Schultz KA; Welsh JB; Shin JJ
    Diabetes Technol Ther; 2015 Aug; 17(8):542-7. PubMed ID: 26237308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy.
    Deiss D; Hartmann R; Hoeffe J; Kordonouri O
    Pediatr Diabetes; 2004 Sep; 5(3):117-21. PubMed ID: 15450005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AIDA: an automated insulin dosage advisor.
    Lehmann ED; Deutsch T
    Proc Annu Symp Comput Appl Med Care; 1992; ():818-9. PubMed ID: 1482998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial pancreas: an emerging approach to treat Type 1 diabetes.
    Kumareswaran K; Evans ML; Hovorka R
    Expert Rev Med Devices; 2009 Jul; 6(4):401-10. PubMed ID: 19572795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
    Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention].
    Buysschaert M; Maes M; Hermans MP
    Acta Clin Belg; 1997; 52(4):211-8. PubMed ID: 9412121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.
    Kaufman FR; Gibson LC; Halvorson M; Carpenter S; Fisher LK; Pitukcheewanont P
    Diabetes Care; 2001 Dec; 24(12):2030-4. PubMed ID: 11723078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).
    Schaepelynck-Bélicar P; Vague P; Simonin G; Lassmann-Vague V
    Diabetes Metab; 2003 Dec; 29(6):608-12. PubMed ID: 14707890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial.
    Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
    Diabetes Technol Ther; 2014 May; 16(5):310-6. PubMed ID: 24716820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of education and self-monitoring of blood glucose on glycosylated hemoglobin in type I diabetes. A controlled 18-month trial in a representative population.
    Terént A; Hagfall O; Cederholm U
    Acta Med Scand; 1985; 217(1):47-53. PubMed ID: 3883704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Home glucose monitoring with microcomputer.
    Huang SW
    J Singapore Paediatr Soc; 1986; 28(3-4):266-70. PubMed ID: 3298858
    [No Abstract]   [Full Text] [Related]  

  • 60. Avoiding hypoglycemia: the use of insulin pump combined with continuous glucose monitor in type 1 diabetes crossing a Rocky Gorge.
    Thomakos P; Vazeou A; Sakkas D; Panagopoulos G; Anifantakis K; Smyrnaki P; Arvanitaki T; Kyrlaki E; Kefalogiannis N; Mamoulakis D; Pappas A; Mitrakou A
    QJM; 2018 Sep; 111(9):629-633. PubMed ID: 29939323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.